vTv Therapeutics (VTVT) Assets (2014 - 2026)

vTv Therapeutics has disclosed Assets across 13 years of filings, most recently posting $98.8 million for Q1 2026.

• Assets for Q1 2026 came in at $98.8 million, up 208.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $98.8 million (up 208.53% YoY), and the FY2025 annual result was $89.9 million, up 134.93% from the prior year.
• Assets came in at $98.8 million for Q1 2026 at vTv Therapeutics, up from $89.9 million in the prior quarter.
• In the past five years, Assets ranged from a high of $99.5 million in Q3 2025 to a low of $11.0 million in Q4 2023.
• The 5-year median for Assets is $35.5 million (2022), against an average of $43.1 million.
• Across the five-year window, Assets tumbled 66.85% in 2023 and surged 247.3% in 2024, its largest moves.
• vTv Therapeutics' Assets stood at $33.2 million in 2022, then sank by 66.85% to $11.0 million in 2023, then soared by 247.3% to $38.3 million in 2024, then jumped by 134.93% to $89.9 million in 2025, then gained by 9.92% to $98.8 million in 2026.
• The last three Assets figures came in at $98.8 million (Q1 2026), $89.9 million (Q4 2025), and $99.5 million (Q3 2025), per Business Quant data.